Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression

Neuropharmacology

Volumn 61, Issue 1-2, 2011, Pages 336-346

  Nollet, Mathieu ^a   Gaillard, Philippe ^a,b   Minier, Frédéric ^a   Tanti, Arnaud ^a   Belzung, Catherine ^a   Leman, Samuel ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Antidepressant; Depression; Dorsomedial perifornical hypothalamic area; Dual orexin receptor antagonist; Melanin concentrating hormone; Orexin hypocretin

Indexed keywords

ALMOREXANT; ANTIDEPRESSANT AGENT; FLUOXETINE; MELANIN CONCENTRATING HORMONE; OREXIN; OREXIN 2 RECEPTOR; PROTEIN FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; LATERAL HYPOTHALAMUS; MALE; MOUSE; NERVE STIMULATION; NONHUMAN; PHYSICAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSAL REACTION; STRESS; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; NEURONS; NEUROPEPTIDES; RANDOM ALLOCATION;

EID: 79957807886     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.04.022     Document Type: Article

References (63)

1. Adamantidis, A., de Lecea, L., 2008. Physiological arousal: a role for hypothalamic systems. Cell. Mol. Life Sci. 65, 1475-1488.
2. Al-Barazanji, K.A., Wilson, S., Baker, J., Jessop, D.S., Harbuz, M.S., 2001. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol. 13, 421-424. (Pubitemid 32377556)
3. Allard, J.S., Tizabi, Y., Shaffery, J.P., Trouth, C.O., Manaye, K., 2004. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 38, 311-315. (Pubitemid 39298731)
4. Armitage, R., Hoffmann, R.F., 2001. Sleep EEG, depression and gender. Sleep Med. Rev. 5, 237-246.
5. Bambico, F.R., Nguyen, N.T., Gobbi, G., 2009. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur. Neuropsychopharmacol. 19, 215-228.
6. Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van Gerven, J., de Haas, S.L., Hess, P., Qiu, C., Buchmann, S., Scherz, M., Weller, T., Fischli, W., Clozel, M., Jenck, F., 2007. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med. 13, 150-155.
7. Brundin, L., Bjorkqvist, M., Petersen, A., Traskman-Bendz, L., 2007. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 17, 573-579.
8. Brundin, L., Bjorkqvist, M., Traskman-Bendz, L., Petersen, A., 2009. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. J. Affect. Disord. 113, 179-182.
9. Chang, H., Saito, T., Ohiwa, N., Tateoka, M., Deocaris, C.C., Fujikawa, T., Soya, H., 2007. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stressinduced ACTH responses in conscious rats. Neurosci. Res. 57, 462-466.
10. Chung, S., Hopf, F.W., Nagasaki, H., Li, C.Y., Belluzzi, J.D., Bonci, A., Civelli, O., 2009. The melanin-concentrating hormone system modulates cocaine reward. Proc. Natl. Acad. Sci. U. S. A. 106, 6772-6777.
11. David, D.J., Klemenhagen, K.C., Holick, K.A., Saxe, M.D., Mendez, I., Santarelli, L., Craig, D.A., Zhong, H., Swanson, C.J., Hegde, L.G., Ping, X.I., Dong, D., Marzabadi, M.R., Gerald, C.P., Hen, R., 2007. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4- methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 321, 237-248.
12. de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M., Sutcliffe, J.G., 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 95, 322-327.
13. DiMicco, J.A., Samuels, B.C., Zaretskaia, M.V., Zaretsky, D.V., 2002. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol. Biochem. Behav. 71, 469-480.
14. Drevets, W.C., Price, J.L., Furey, M.L., 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 213, 93-118.
15. Estabrooke, I.V., McCarthy, M.T., Ko, E., Chou, T.C., Chemelli, R.M., Yanagisawa, M., Saper, C.B., Scammell, T.E., 2001. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656-1662. (Pubitemid 32182206)
16. Fadel, J., Bubser, M., Deutch, A.Y., 2002. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J. Neurosci. 22, 6742-6746. (Pubitemid 35386430)
17. Fanselow, M.S., Dong, H.W., 2010. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65, 7-19.
18. Feng, P., Hu, Y., Li, D., Vurbic, D., Fan, H.,Wang, S., Strohl, K.P., 2009. The effect of clomipramine onwake/sleep and orexinergic expression in rats. J. Psychopharmacol. 23, 559-566.
19. Feng, P., Vurbic, D.,Wu, Z., Hu, Y., Strohl, K.P., 2008. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J. Psychopharmacol. 22, 784-791.
20. Feng, P., Vurbic, D., Wu, Z., Strohl, K.P., 2007. Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res. 1154, 163-172. (Pubitemid 46856334)
21. Franklin, K.B.J., Paxinos, G., 2008. The Mouse Brain in Stereotaxic Coordinates, third ed. Elsevier Academic Press, New York.
22. Furlong, T.M., Vianna, D.M., Liu, L., Carrive, P., 2009. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 30, 1603-1614.
23. Grady, S.P., Nishino, S., Czeisler, C.A., Hepner, D., Scammell, T.E., 2006. Diurnal variation in CSF orexin-A in healthy male subjects. Sleep 29, 295-297. (Pubitemid 44019951)
24. Hagan, J.J., Leslie, R.A., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S., Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P., Munton, R.P., Ashmeade, T.E., Shah, A.S., Hatcher, J.P., Hatcher, P.D., Jones, D.N., Smith, M.I., Piper, D.C., Hunter, A.J., Porter, R.A., Upton, N., 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U. S. A. 96, 10911-10916.
25. Harris, G.C., Aston-Jones, G., 2006. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29, 571-577. (Pubitemid 44416459)
26. Harris, G.C., Wimmer, M., Aston-Jones, G., 2005. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437, 556-559. (Pubitemid 41613553)
27. Harris, G.C., Wimmer, M., Randall-Thompson, J.F., Aston-Jones, G., 2007. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res. 183, 43-51.
28. Hassani, O.K., Lee, M.G., Jones, B.E., 2009. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc. Natl. Acad. Sci. U. S. A. 106, 2418-2422.
29. Hsu, D.T., Price, J.L., 2007. Midline and intralaminar thalamic connections with the orbital and medial prefrontal networks in macaque monkeys. J. Comp. Neurol. 504, 89-111.
30. Hsu, D.T., Price, J.L., 2009. Paraventricular thalamic nucleus: subcortical connections and innervation by serotonin, orexin, and corticotropin-releasing hormone in macaque monkeys. J. Comp. Neurol. 512, 825-848.
31. Ida, T., Nakahara, K., Murakami, T., Hanada, R., Nakazato, M., Murakami, N., 2000. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 270, 318-323.
32. Kennedy, A.R., Todd, J.F., Dhillo, W.S., Seal, L.J., Ghatei, M.A., O'Toole, C.P., Jones, M., Witty, D., Winborne, K., Riley, G., Hervieu, G., Wilson, S., Bloom, S.R., 2003. Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. J. Neuroendocrinol. 15, 268-272. (Pubitemid 36266894)
33. Kulkarni, S.K., Dhir, A., 2007. Effect of various classes of antidepressants in behavioral paradigms of despair. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1248-1254.
34. Kumar, S., Szymusiak, R., Bashir, T., Rai, S., McGinty, D., Alam, M.N., 2007. Effects of serotonin on perifornical-lateral hypothalamic area neurons in rat. Eur. J. Neurosci. 25, 201-212.
35. Kuru, M., Ueta, Y., Serino, R., Nakazato, M., Yamamoto, Y., Shibuya, I., Yamashita, H., 2000. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11, 1977-1980. (Pubitemid 30429147)
36. Lutter, M., Krishnan, V., Russo, S.J., Jung, S., McClung, C.A., Nestler, E.J., 2008. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 28, 3071-3075. (Pubitemid 351442272)
37. Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B., Yanagisawa, M., Elmquist, J.K., 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6-25.
38. Martinez, G.S., Smale, L., Nunez, A.A., 2002. Diurnal and nocturnal rodents show rhythms in orexinergic neurons. Brain Res. 955, 1-7. (Pubitemid 35284829)
39. Mieda, M., Sakurai, T., 2009. Integrative physiology of orexins and orexin receptors. CNS Neurol. Disord. Drug Targets 8, 281-295.
40. Muraki, Y., Yamanaka, A., Tsujino, N., Kilduff, T.S., Goto, K., Sakurai, T., 2004. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J. Neurosci. 24, 7159-7166. (Pubitemid 39096381)
41. Nakamura, T., Uramura, K., Nambu, T., Yada, T., Goto, K., Yanagisawa, M., Sakurai, T., 2000. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873, 181-187. (Pubitemid 30468504)
42. Nestler, E.J., Carlezon Jr., W.A., 2006. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151-1159.
43. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G., Kilduff, T.S., 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015. (Pubitemid 28543775)
44. Pissios, P., Bradley, R.L., Maratos-Flier, E., 2006. Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions. Endocr. Rev. 27, 606-620.
45. Price, J.L., Drevets, W.C., 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology 35, 192-216.
46. Qu, D., Ludwig, D.S., Gammeltoft, S., Piper, M., Pelleymounter, M.A., Cullen, M.J., Mathes, W.F., Przypek, R., Kanarek, R., Maratos-Flier, E., 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243-247. (Pubitemid 26090645)
47. Roy, M., David, N., Cueva, M., Giorgetti, M., 2007. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biol. Psychiatry 61, 174-180. (Pubitemid 46072783)
48. Sakamoto, F., Yamada, S., Ueta, Y., 2004. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 118, 183-191.
49. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J., Yanagisawa, M., 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding behavior. Cell 92, 573-585. (Pubitemid 28101119)
50. Salomon, R.M., Ripley, B., Kennedy, J.S., Johnson, B., Schmidt, D., Zeitzer, J.M., Nishino, S., Mignot, E., 2003. Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96-104. (Pubitemid 36859768)
51. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., Hen, R., 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. (Pubitemid 36962615)
52. Shaffer, J.P., 1995. Multiple hypothesis testing. Annu. Rev. Clin. Psychol. 46, 561-584.
53. Spinazzi, R., Andreis, P.G., Rossi, G.P., Nussdorfer, G.G., 2006. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev. 58, 46-57.
54. Steru, L., Chermat, R., Thierry, B., Simon, P., 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol. (Berl.) 85, 367-370.
55. Surget, A., Belzung, C., 2008. Unpredictable chronic mild stress in mice. In: Kalueff, A.V., LaPorte, J.L. (Eds.), Experimental Animal Models in Neurobehavioral Research. Nova Science Publishers, New York, pp. 79-112.
56. Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., Belzung, C., 2008. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293-301.
57. Surget, A., Wang, Y., Leman, S., Ibarguen-Vargas, Y., Edgar, N., Griebel, G., Belzung, C., Sibille, E., 2009. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34, 1363-1380.
58. Taheri, S., Gardiner, J., Hafizi, S., Murphy, K., Dakin, C., Seal, L., Small, C., Ghatei, M., Bloom, S., 2001. Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport 12, 459-464. (Pubitemid 32173948)
59. Trivedi, P., Yu, H., MacNeil, D.J., Van der Ploeg, L.H., Guan, X.M., 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438, 71-75. (Pubitemid 28517837)
60. Winsky-Sommerer, R., Yamanaka, A., Diano, S., Borok, E., Roberts, A.J., Sakurai, T., Kilduff, T.S., Horvath, T.L., de, L.L., 2004. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24, 11439-11448. (Pubitemid 39658279)
61. Yamanaka, A., Beuckmann, C.T., Willie, J.T., Hara, J., Tsujino, N., Mieda, M., Tominaga, M., Yagami, K., Sugiyama, F., Goto, K., Yanagisawa, M., Sakurai, T., 2003. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701-713. (Pubitemid 36694778)
62. Yoshida, K., McCormack, S., Espana, R.A., Crocker, A., Scammell, T.E., 2006. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845-861.
63. Yoshida, Y., Fujiki, N., Nakajima, T., Ripley, B., Matsumura, H., Yoneda, H., Mignot, E., Nishino, S., 2001. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075-1081.